Decriminalization of Diverted Buprenorphine in Burlington, Vermont and Philadelphia: An Intervention to Reduce Opioid Overdose Deaths.
作者信息
Pozo Brandon Del, Krasner Lawrence S, George Sarah F
机构信息
Brandon del Pozo, Ph.D., M.P.A., M.A., is a Postdoctoral Fellow, Miriam Hospital/Warren Alpert Medical School of Brown University, and Research Fellow, Global Law Enforcement and Public Health Association Lawrence S. Krasner, J.D., is the District Attorney of Philadelphia. Sarah F. George, J.D., is a a State's Attorney, Chittenden County, Vermont.
出版信息
J Law Med Ethics. 2020 Jun;48(2):373-375. doi: 10.1177/1073110520935353.
Abstract
摘要
相似文献
1
Decriminalization of Diverted Buprenorphine in Burlington, Vermont and Philadelphia: An Intervention to Reduce Opioid Overdose Deaths.佛蒙特州伯灵顿市和宾夕法尼亚州费城将被挪用的丁丙诺啡合法化：一项减少阿片类药物过量致死的干预措施。
J Law Med Ethics. 2020 Jun;48(2):373-375. doi: 10.1177/1073110520935353.
2
Beliefs and Attitudes about Vermont's Buprenorphine Decriminalization Law among Clinicians Who Prescribe Buprenorphine.在开具丁丙诺啡的临床医生中，对佛蒙特州丁丙诺啡非刑罪化法律的信念和态度。
Subst Use Misuse. 2024;59(1):150-153. doi: 10.1080/10826084.2023.2262014. Epub 2023 Dec 1.
3
Attitudes and beliefs about Vermont's 2021 buprenorphine decriminalization law among residents who use illicit opioids.非法使用阿片类药物者对佛蒙特州 2021 年丁丙诺啡非刑罪化法律的态度和信念。
Drug Alcohol Depend. 2023 Sep 1;250:110879. doi: 10.1016/j.drugalcdep.2023.110879. Epub 2023 Jul 6.
4
CommunityStat: A Public Health Intervention to Reduce Opioid Overdose Deaths in Burlington, Vermont, 2017-2020.社区统计：2017 - 2020年佛蒙特州伯灵顿市减少阿片类药物过量死亡的公共卫生干预措施
Contemp Drug Probl. 2022 Mar;49(1):3-19. doi: 10.1177/00914509211052107. Epub 2021 Oct 6.
5
Commentary on Glanz et al.: Longer buprenorphine treatment duration is associated with lower rates of opioid overdose, but can we address barriers to staying in treatment?关于格兰兹等人的评论：丁丙诺啡治疗时间延长与阿片类药物过量使用率降低有关，但我们能否解决维持治疗的障碍？
Addiction. 2023 Jan;118(1):108-109. doi: 10.1111/add.16032. Epub 2022 Aug 31.
6
Vermont responds to its opioid crisis.佛蒙特州应对其阿片类药物危机。
Prev Med. 2015 Nov;80:10-1. doi: 10.1016/j.ypmed.2015.04.002. Epub 2015 Apr 11.
7
Improve Access to Care for Opioid Use Disorder: A Call to Eliminate the X-Waiver Requirement Now.改善阿片类药物使用障碍的治疗可及性：呼吁立即消除X豁免要求。
Ann Emerg Med. 2021 Aug;78(2):220-222. doi: 10.1016/j.annemergmed.2021.03.023. Epub 2021 May 7.
8
Legal Authority for Emergency Medical Services to Increase Access to Buprenorphine Treatment for Opioid Use Disorder.法律授权紧急医疗服务机构增加美沙酮治疗阿片类药物使用障碍的机会。
Ann Emerg Med. 2021 Jul;78(1):102-108. doi: 10.1016/j.annemergmed.2021.01.017. Epub 2021 Mar 27.
9
Injecting Opioid Use Disorder Treatment in Jails and Prisons: The Potential of Extended-release Buprenorphine in the Carceral Setting.将阿片类使用障碍治疗纳入监狱：延长释放丁丙诺啡在监禁环境中的潜力。
J Addict Med. 2022;16(4):396-398. doi: 10.1097/ADM.0000000000000942. Epub 2021 Dec 23.
10
A health crisis within a health crisis: Opioid access in the COVID-19 pandemic.健康危机中的健康危机：新冠大流行中的阿片类药物获取问题。
Subst Abus. 2021;42(2):148-152. doi: 10.1080/08897077.2021.1900981. Epub 2021 Apr 13.
引用本文的文献
1
Police Knowledge, Attitudes, and Beliefs About Opioid Addiction Treatment and Harm Reduction: A Survey of Illinois Officers.警察对阿片类药物成瘾治疗及减少伤害的认知、态度和信念：伊利诺伊州警官调查
J Drug Issues. 2025 Apr;55(2):239-259. doi: 10.1177/00220426231212567. Epub 2023 Nov 3.
2
"Either way, they will use. And so, probably, would you:" A critical discourse analysis of harm reduction portrayal in United States opinion news media.“无论哪种方式，他们都会使用。所以，你可能也会：”对美国观点新闻媒体中减少伤害描述的批判性话语分析。
Int J Drug Policy. 2025 Jun;140:104801. doi: 10.1016/j.drugpo.2025.104801. Epub 2025 Apr 11.
3
Beliefs of US chiefs of police about substance use disorder, fentanyl exposure, overdose response, and use of discretion: results from a national survey.美国警察局长对物质使用障碍、芬太尼暴露、过量用药应对及自由裁量权使用的看法：一项全国性调查结果
Health Justice. 2025 Mar 5;13(1):13. doi: 10.1186/s40352-025-00318-8.
4
Drug Decriminalization, Fentanyl, and Fatal Overdoses in Oregon.药物非刑罪化、芬太尼与俄勒冈州的致命过量用药
JAMA Netw Open. 2024 Sep 3;7(9):e2431612. doi: 10.1001/jamanetworkopen.2024.31612.
5
Antecedents of fatal overdose in an adult cohort identified through administrative record linkage in Indiana, 2015-2022.印第安纳州 2015-2022 年通过行政记录关联确定的成人队列中致命过量用药的前因。
Drug Alcohol Depend. 2023 Jun 1;247:109891. doi: 10.1016/j.drugalcdep.2023.109891. Epub 2023 Apr 22.
6
Buprenorphine and opioid analgesics: Dispensation and discontinuity among accidental overdose fatalities in the Indianapolis metropolitan area, 2016-2021.丁丙诺啡和阿片类镇痛药：印第安纳波利斯都会区 2016-2021 年意外过量死亡者的配给和中断情况。
J Subst Use Addict Treat. 2023 Jul;150:209053. doi: 10.1016/j.josat.2023.209053. Epub 2023 Apr 25.
7
Scope of, Motivations for, and Outcomes Associated with Buprenorphine Diversion in the United States: A Scoping Review.美国丁丙诺啡转用的范围、动机和结果：范围综述。
Subst Use Misuse. 2023;58(5):685-697. doi: 10.1080/10826084.2023.2177972. Epub 2023 Feb 20.
8
Buprenorphine involvement in opioid overdose deaths: A retrospective analysis of postmortem toxicology in Marion County, Indiana, 2015-2021.丁丙诺啡与阿片类药物过量死亡的关系：对2015 - 2021年印第安纳州马里恩县尸检毒理学的回顾性分析。
Drug Alcohol Depend Rep. 2023 Mar;6. doi: 10.1016/j.dadr.2023.100131. Epub 2023 Jan 4.
9
Reducing the Iatrogenesis of Police Overdose Response: Time Is of the Essence.减少警方过量用药应对中的医源性问题：时间至关重要。
Am J Public Health. 2022 Sep;112(9):1236-1238. doi: 10.2105/AJPH.2022.306987. Epub 2022 Jul 21.
10
CommunityStat: A Public Health Intervention to Reduce Opioid Overdose Deaths in Burlington, Vermont, 2017-2020.社区统计：2017 - 2020年佛蒙特州伯灵顿市减少阿片类药物过量死亡的公共卫生干预措施
Contemp Drug Probl. 2022 Mar;49(1):3-19. doi: 10.1177/00914509211052107. Epub 2021 Oct 6.
本文引用的文献
1
Demystifying buprenorphine misuse: Has fear of diversion gotten in the way of addressing the opioid crisis?揭开丁丙诺啡滥用的神秘面纱：对药物转移的恐惧是否阻碍了阿片类药物危机的解决？
Subst Abus. 2019;40(2):148-153. doi: 10.1080/08897077.2019.1572052. Epub 2019 Apr 22.
2
Understanding the use of diverted buprenorphine.理解丁丙诺啡的转用。
Drug Alcohol Depend. 2018 Dec 1;193:117-123. doi: 10.1016/j.drugalcdep.2018.09.007. Epub 2018 Oct 12.
3
Suboxone: Rationale, Science, Misconceptions.丁丙诺啡/纳洛酮：基本原理、科学依据与误解
Ochsner J. 2018 Spring;18(1):23-29.
4
A qualitative study comparing physician-reported barriers to treating addiction using buprenorphine and extended-release naltrexone in U.S. office-based practices.一项比较美国基层医疗实践中医生报告的使用丁丙诺啡和纳曲酮治疗成瘾的障碍的定性研究。
Int J Drug Policy. 2018 Apr;54:9-17. doi: 10.1016/j.drugpo.2017.11.021. Epub 2018 Jan 8.
5
Barriers to Medications for Addiction Treatment: How Stigma Kills.成瘾治疗药物的障碍：耻辱感如何致人死亡。
Subst Use Misuse. 2018 Jan 28;53(2):330-333. doi: 10.1080/10826084.2017.1363238. Epub 2017 Sep 29.
6
Public health errors: costing lives, millions at a time.公共卫生失误：每次都要付出生命代价，耗费数百万资金。
J Public Health Manag Pract. 2010 May-Jun;16(3):211-5. doi: 10.1097/PHH.0b013e3181bee698.
Zotero 插件